Thursday, October 26th, 2017
CHARLOTTE, N.C. – October 26, 2017– Saebo, Inc., a medical device company specializing in affordable and novel clinical solutions designed to improve mobility and function, announced on Thursday a new patent awarded to address hand function following a neurological injury. Saebo’s latest technology transforms the neuroprosthetic industry by embedding biofeedback (EMG) sensors, along with stimulation electrodes, into an affordable neuro glove, so clients can improve independence and motor control.
Saebo developed the novel sensor-based stimulation program after many years of success with their EMG-triggered stimulation product, the Saebo MyoTrac Infiniti, a total-body stimulation device designed to assist in improving strength and function.
“We are extremely excited to receive notification of allowance from the U.S. Patent and Trademark Office for this latest breakthrough product,” says Saebo co-founder, Henry Hoffman. “Many neurological clients are unable to use their hand independently due to weakness and spasticity. Our new biofeedback sensor-based stimulation system can help clients decrease their spasticity while simultaneously delivering electrical stimulation to the weaker muscles responsible for hand opening. Using the client’s very own EMG signal, the advanced program provides electrical stimulation precisely and accurately, so functional grasp and release can successfully occur.”
The revolutionary neuroprosthetic is comfortable, lightweight and low-profile. The device monitors spasticity in the arm and hand using embedded sensors. Once the client deactivates or lowers the level of spasticity, the neuro glove delivers the appropriate amount of stimulation to the finger extensors.
“As we celebrate our 15th year in the industry, we continue to learn how to innovate and adapt based on the latest scientific and clinical information available,” stated Hoffman. “Embedding biofeedback electrical stimulation into a proprietary mechanically-driven glove truly is the ideal scenario for clinicians and patients moving forward, and we are proud to lead the industry in this new category.”
Saebo, Inc. is a medical device company primarily engaged in the discovery, development, and commercialization of affordable and novel clinical solutions designed to improve mobility and function in individuals suffering from neurological and orthopedic conditions. With a vast network of Saebo-trained clinicians spanning six continents, Saebo has helped over 250,000 clients around the globe achieve a new level of independence. For more information about Saebo, please visit www.www.saebo.com.